Hair Repigmentation During Cerebrolysin Therapy

• Status: Completed
• Trial end date: 2016-12-23
• Target enrollment: 0
• Participant gender: All

Summary

Open-label histological study of scalp biopsies from patients undergoing treatment with Cerebrolysin as therapy for cerebrovascular disease. The aim is to assess by histological techniques the causes of follicular repigmentation that occurs during the Cerebrolysin treatment.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Universidad Autonoma de Nuevo Leon
• Collaborator: Hospital Universitario Dr. Jose E. Gonzalez
• Treatments: Cerebrolysin

Criteria

Inclusion Criteria:

• Known neurologist prescription for Cerebrolysin treatment due ischemic or hemorrhagic stroke, traumatic brain injury or dementia.

• Age-related white or gray hair.

• Above 40 years old

• Voluntarily consents in written informed consent by the principal or legal representative

Exclusion Criteria:

• Patients with a diagnosis of Chronic Kidney Disease (CKD).

• Known history of seizures, epilepsy, or hypersensitivity to one or any drug components.

• Pregnant patients.

• Patients with a history of recent treatment of hair coloring products.